Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kovar

Showing results (851-860 of 949) with videos related to

Pageof 95
Sort By:
Wellcome Open Research|May 29, 2024
Household overcrowding and risk of SARS-CoV-2: analysis of the Virus Watch prospective community cohort study in England and WalesRobert W Aldridge, Helen Pineo, Ellen Fragaszy, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2007
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studiesYunsong Tong, Akiyo Claiborne, Magdalena Pyzytulinska, et al.
JCI Insight|August 8, 2024
Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.
Journal for Immunotherapy of Cancer|April 18, 2025
Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2vHana Matuskova, Pavel Marasek, Vladyslav Mazhara, et al.
Oncotarget|May 19, 2016
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse modelTsion Zewdu Minas, Didier Surdez, Tahereh Javaheri, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 InhibitorsYunsong Tong, Alan S Florjancic, Rick F Clark, et al.
Cell Death & Disease|October 14, 2016
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort studyAndrew C Hayward, Ellen B Fragaszy, Alison Bermingham, et al.
BMC Microbiology|July 10, 2012
Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomesXiang Qin, Jessica R Galloway-Peña, Jouko Sillanpaa, et al.
Journal of Medicinal Chemistry|July 31, 2007
Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitorsLe Wang, Gerard M Sullivan, Laura A Hexamer, et al.
Pageof 95

Showing results (851-860 of 949) with videos related to

Sort By:
Pageof 95
Wellcome Open Research|May 29, 2024
Household overcrowding and risk of SARS-CoV-2: analysis of the Virus Watch prospective community cohort study in England and WalesRobert W Aldridge, Helen Pineo, Ellen Fragaszy, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2007
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studiesYunsong Tong, Akiyo Claiborne, Magdalena Pyzytulinska, et al.
JCI Insight|August 8, 2024
Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.
Journal for Immunotherapy of Cancer|April 18, 2025
Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2vHana Matuskova, Pavel Marasek, Vladyslav Mazhara, et al.
Oncotarget|May 19, 2016
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse modelTsion Zewdu Minas, Didier Surdez, Tahereh Javaheri, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 InhibitorsYunsong Tong, Alan S Florjancic, Rick F Clark, et al.
Cell Death & Disease|October 14, 2016
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort studyAndrew C Hayward, Ellen B Fragaszy, Alison Bermingham, et al.
BMC Microbiology|July 10, 2012
Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomesXiang Qin, Jessica R Galloway-Peña, Jouko Sillanpaa, et al.
Journal of Medicinal Chemistry|July 31, 2007
Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitorsLe Wang, Gerard M Sullivan, Laura A Hexamer, et al.
Pageof 95